Yong-chun Song
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Risk-adapted stereotactic body radiation therapy for the treatment of large (>3 cm) primary lung cancer with or without histologic confirmation: A propensity score matched and weighted analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 29, 2024
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 02, 2023
Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases.
Journal: Cancer science
Published: June 28, 2022
Celiac Plexus Block After Stereotactic Body Radiotherapy Improves Pain Relief in Locally Advanced Pancreatic Cancer.
Journal: Journal of pain research
Published: January 26, 2020
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.
Journal: Cancer science
Published: April 09, 2019
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump.
Journal: OncoTargets and therapy
Published: July 16, 2016
Similar Outcomes of Standard Radiotherapy and Hypofractionated Radiotherapy Following Breast-Conserving Surgery.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: August 04, 2015
Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.
Journal: Oncotarget
Published: December 17, 2014
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases.
Journal: OncoTargets and therapy
Published: June 25, 2014
Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Journal: Journal of clinical laboratory analysis
Published: May 26, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026